T-cadherin Is Essential for Adiponectin-mediated Revascularization*
暂无分享,去创建一个
Ryosuke Kikuchi | Kazuto Nakamura | Kazuto Nakamura | S. Yoshida | K. Walsh | Kenneth Walsh | M. Silver | B. Ranscht | Sumiko Yoshida | Barbara Ranscht | Marcy Silver | Jennifer L. Parker-Duffen | Ulrich Tigges | Martin S. Denzel | M. Denzel | Ulrich Tigges | Jennifer L Parker-Duffen | R. Kikuchi
[1] R. Klemenz,et al. Advances in Brief Increased Expression of H/T-Cadherin in Tumor-penetrating Blood Vessels 1 , 2022 .
[2] S. Kihara,et al. Adiponectin Promotes Revascularization of Ischemic Muscle through a Cyclooxygenase 2-Dependent Mechanism , 2009, Molecular and Cellular Biology.
[3] J. Isner,et al. Mouse model of angiogenesis. , 1998, The American journal of pathology.
[4] Jeroen J. Bax,et al. A decline in walking distance predicts long-term outcome in patients with known or suspected peripheral artery disease , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[5] H. Yoshiji,et al. Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats. , 2007, International journal of molecular medicine.
[6] H. Lodish,et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[8] N. Turner,et al. Overexpression of the Adiponectin Receptor AdipoR1 in Rat Skeletal Muscle Amplifies Local Insulin Sensitivity , 2012, Endocrinology.
[9] S. Kihara,et al. Adiponectin Stimulates Angiogenesis in Response to Tissue Ischemia through Stimulation of AMP-activated Protein Kinase Signaling* , 2004, Journal of Biological Chemistry.
[10] M. Bohlooly-y,et al. Opposing Effects of Adiponectin Receptors 1 and 2 on Energy Metabolism , 2007, Diabetes.
[11] C. Nishitani,et al. Diverse Functions of Pulmonary Collectins in Host Defense of the Lung , 2012, Journal of biomedicine & biotechnology.
[12] M. Philippova,et al. Identification of an atypical lipoprotein‐binding protein from human aortic smooth muscle as T‐cadherin , 1998, FEBS letters.
[13] R. Cardiff,et al. T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. , 2008, Cancer research.
[14] A. Andreeva,et al. Cadherin 13 in cancer , 2010, Genes, chromosomes & cancer.
[15] R. Collins,et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies , 2009, The Lancet.
[16] NoriyukiOuchi,et al. Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-α Expression , 2009 .
[17] L. Campbell,et al. Human adiponectin binds to bacterial lipopolysaccharide. , 2006, Biochemical and biophysical research communications.
[18] P. Erne,et al. Expression of cell adhesion molecule T-cadherin in the human vasculature , 2001, Histochemistry and Cell Biology.
[19] P. Quax,et al. Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. , 2008, Annals of vascular surgery.
[20] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[21] P. Erne,et al. Atypical GPI-Anchored T-Cadherin Stimulates Angiogenesis In Vitro and In Vivo , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[22] K. Walsh,et al. Adiponectin and cardiovascular inflammatory responses , 2007, Current atherosclerosis reports.
[23] B. Ranscht,et al. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.
[24] M. Montagnana,et al. A variant upstream of the CDH13 adiponectin receptor gene and metabolic syndrome in Swedes. , 2011, The American journal of cardiology.
[25] P. Erne,et al. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[26] P. Erne,et al. Identification of Proteins Associating with Glycosylphosphatidylinositol- Anchored T-Cadherin on the Surface of Vascular Endothelial Cells: Role for Grp78/BiP in T-Cadherin-Dependent Cell Survival , 2008, Molecular and Cellular Biology.
[27] M. Bronner‐Fraser,et al. T-cadherin expression alternates with migrating neural crest cells in the trunk of the avian embryo. , 1991, Development.
[28] P. Erne,et al. LDL induces intracellular signalling and cell migration via atypical LDL-binding protein T-cadherin , 2005, Molecular and Cellular Biochemistry.
[29] M. Birnbaum,et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.
[30] Ivan Martin,et al. Use of multicellular tumor spheroids to dissect endothelial cell–tumor cell interactions: A role for T‐cadherin in tumor angiogenesis , 2007, FEBS letters.
[31] Wen-Harn Pan,et al. A Genome-Wide Association Study Reveals a Quantitative Trait Locus of Adiponectin on CDH13 That Predicts Cardiometabolic Outcomes , 2011, Diabetes.
[32] Christian Gieger,et al. Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations , 2009, Human molecular genetics.
[33] P. Erne,et al. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells. , 2012, Cardiovascular research.
[34] S. Kash,et al. Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetes. , 2007, Endocrinology.
[35] Yun Li,et al. Genome-wide association study for adiponectin levels in Filipino women identifies CDH13 and a novel uncommon haplotype at KNG1-ADIPOQ. , 2010, Human molecular genetics.
[36] J. Pollard,et al. Proangiogenic Contribution of Adiponectin toward Mammary Tumor Growth In vivo , 2009, Clinical Cancer Research.
[37] J. Martínez,et al. The − 11391 G/A Polymorphism of the Adiponectin Gene Promoter is Associated with Metabolic Syndrome Traits and the Outcome of an Energy-restricted Diet in Obese Subjects , 2008, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[38] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[39] P. Froguel,et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.
[40] R. Sacco,et al. Genetic loci for blood lipid levels identified by linkage and association analyses in Caribbean Hispanics[S] , 2011, Journal of Lipid Research.
[41] V. Cachofeiro,et al. The Effects of Adiponectin and Leptin on Human Endothelial Cell Proliferation: A Live-Cell Study , 2012, Journal of Vascular Research.
[42] P. Erne,et al. T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. , 2004, Cardiovascular research.
[43] S. Kihara,et al. Adiponectin Suppresses Pathological Microvessel Formation in Retina Through Modulation of Tumor Necrosis Factor-α Expression , 2009, Circulation Research.
[44] Y. Kokubo,et al. CDH13 gene coding t‐cadherin influences variations in plasma adiponectin levels in the Japanese population , 2012, Human mutation.
[45] Y. Hayashi,et al. Adiponectin and AdipoR1 regulate PGC-1α and mitochondria by Ca2+ and AMPK/SIRT1 , 2010, Nature.
[46] S. Kihara,et al. Adiponectin Stimulates Angiogenesis by Promoting Cross-talk between AMP-activated Protein Kinase and Akt Signaling in Endothelial Cells* , 2004, Journal of Biological Chemistry.
[47] Yasser Khalil,et al. The Relationship of Peripheral Arterial Disease and Metabolic Syndrome Prevalence in Asymptomatic US Adults 40 Years and Older: Results From the National Health and Nutrition Examination Survey (1999–2004) , 2012, Journal of clinical hypertension.
[48] K. Walsh,et al. Adipokines in inflammation and metabolic disease , 2011, Nature Reviews Immunology.
[49] N. Cook,et al. High-Molecular-Weight and Total Adiponectin Levels and Incident Symptomatic Peripheral Artery Disease in Women: A Prospective Investigation , 2011, Circulation.
[50] T. Beaty,et al. Adiponectin concentrations: a genome-wide association study. , 2010, American journal of human genetics.
[51] K. Walsh,et al. Targeting adiponectin for cardioprotection , 2006, Expert opinion on therapeutic targets.
[52] R. Cardiff,et al. Adiponectin Deficiency Limits Tumor Vascularization in the MMTV-PyV-mT Mouse Model of Mammary Cancer , 2009, Clinical Cancer Research.
[53] M. Philippova,et al. T‐cadherin and signal‐transducing molecules co‐localize in caveolin‐rich membrane domains of vascular smooth muscle cells , 1998, FEBS letters.
[54] P. Erne,et al. Extracellular Cadherin repeat domains EC1 and EC5 of T‐cadherin are essential for its ability to stimulate angiogenic behavior of endothelial cells , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] Yajing Wang,et al. AMP-Activated Protein Kinase Deficiency Enhances Myocardial Ischemia/Reperfusion Injury but Has Minimal Effect on the Antioxidant/Antinitrative Protection of Adiponectin , 2009, Circulation.
[56] S. Kihara,et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2–dependent mechanisms , 2005, Nature Medicine.
[57] H. Randeva,et al. Protective Actions of Globular and Full-Length Adiponectin on Human Endothelial Cells: Novel Insights into Adiponectin-Induced Angiogenesis , 2012, Journal of Vascular Research.
[58] S. Kihara,et al. Adiponectin promotes endothelial progenitor cell number and function , 2008, FEBS Letters.
[59] H. Tiwari,et al. Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network. , 2013, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[60] R J Hinchliffe,et al. Diagnosis and management of peripheral arterial disease , 2012, BMJ : British Medical Journal.
[61] S. Jee,et al. Effects of Smoking and Obesity on the Association Between CDH13 (rs3865188) and Adiponectin Among Korean Men: The KARE Study , 2012, Obesity.
[62] B. Tyrberg,et al. T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion , 2011, Islets.
[63] Dexi Liu,et al. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.
[64] P. Ruiz-Lozano,et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.
[65] David G. Wilkinson,et al. T-cadherin suppresses angiogenesis in vivo by inhibiting migration of endothelial cells , 2007, Angiogenesis.
[66] P. Erne,et al. Integrin‐linked kinase is an essential mediator for T‐cadherin‐dependent signaling via Akt and GSK3β in endothelial cells , 2007 .
[67] T. Voyno-Yasenetskaya,et al. T-cadherin is located in the nucleus and centrosomes in endothelial cells. , 2009, American journal of physiology. Cell physiology.